Skip to main content Accessibility help
×
Home

A case report of schizophrenia and HIV: HAART in association with clozapine

  • Sebastian Sanz-Cortés (a1), Elena Fashho-Rodriguez (a1), Tomás Sánchez-Araña Moreno (a1), Sergio Ruiz-Doblado (a2) and Jorge Marín-Martín (a3)...

Abstract

The anti-psychotic drug management of patients with schizophrenia and HIV-1 infection is problematic. Such individuals are prone to extra-pyramidal reactions on account of HIV-1 induced sub-cortical involvement and exacerbation of cognitive impairment due to underlying CNS infection. Compliance with treatment can be problematic due to a disordered mental state and bone marrow toxicity may also result from the combined effects of anti-psychotic and retroviral agents. It is generally thought that atypical anti-psychotic drugs are the treatment of choice in such cases.

We present the case of a 30-year-old man with a history of schizophrenia who was successfully treated with clozapine following an admission to a psychiatric unit with acute confusional symptoms secondary to HIV-related central nervous system (CNS) involvement.

Copyright

Corresponding author

Correspondence to: Dr Sergio Ruiz-Doblado, Servicio de Psiquiatría, Hospital de la Merced, Avda. Constitución, 2, 41640 Osuna (Sevilla), Spain. Tel & fax: +34 955 077257; E-mail: sergioruiz@ozu.es

References

Hide All
Altschuler, E.L. and Kast, R.E. (2005) The atypical antipsychotic agents ziprasidone, risperidone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Medical Hypotheses. 65: 585586.
American Psychiatric Association Work Group on HIV/AIDS (2000) Practice Guideline for the treatment of patients with HIV/AIDS. American Journal of Psychiatry. 157 (Suppl. 11): 162.
Andreasen, N. (1984) The Scale for the Assessment of Positive Symptoms. Iowa City: University of Iowa College of Medicine.
Baum, S., Ashok, A., Gee, G., et al. (2003) Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy. Journal of Neurovirology. 9(Suppl. 1): 3237.
Della, N.D. and Treisman, G.J. (2005) HIV/AIDS. In: Levenson, J.L. Textbook of Psychosomatic Medicine. Washington: American Psychiatric Publishing, pp. 630–631.
Dettling, M., Muller-Oerlinghausen, B. and Britsch, P. (1998) Clozapine treatment of HIV-associated psychosis – too much bone marrow toxicity? Pharmacopsychiatry. 31: 156157.
Jones-Brando, L.V., Buthod, J.L., Holland, L.E., et al. (1997) Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1. Schizophrenia Research. 25: 6370.
Lera, G. and Zirulnik, J. (1999) Pilot study with clozapine in patients with HIV-associated psicosis and drug-induced parkinsonism. Movement Disorders. 14: 128131.
Lobo, A., Ezquerra, J., Gómez, F., et al. (1979) El Mini-Examen Cognoscitivo. Un test sencillo, práctico, para detectar alteraciones intelectuales en pacientes médicos. Actas Luso-Españolas de Neurología, Psiquiatría y Ciencias Afines. 3: 189202.
Sperner-Unterweger, B. (2005) Immunological aetiology of major psychiatric disorders: Evidence and therapeutic implications. Drugs. 65: 14931520.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed